CanadaAuro-Canagliflozin tablets (Canagliflozin 300 mg) by Auro Pharma Inc., Market Authorization DIN 02510375, lots XQ3025001A and XQ3025004A, are affected and can be recognised by an incorrect DIN printed on the blister card. Verify whether your product is one of these lots, consult your healthcare provider before discontinuing use, contact Auro Pharma Inc. with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Wholesalers
Companies: Auro Pharma Inc., 3700 Steeles Avenue West, Suite 402,, Woodbridge, Ontario, L4L 8K8.
How to identify it
Brand: Auro-Canagliflozin; Product Name: Auro-Canagliflozin; Market Authorization: DIN 02510375; Dosage Form: Tablet; Strength: Canagliflozin 300mg; Lot: XQ3025001A, XQ3025004A
The hazard
Affected lots are labelled with the incorrect DIN found on the blister card.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)